Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04112459
Other study ID # MP-21-2019-2130
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date September 4, 2019
Est. completion date September 4, 2022

Study information

Verified date September 2019
Source St. Justine's Hospital
Contact Atsushi Kawaguchi, MD PhD
Phone +1-(514)912-4247
Email atsushi@ualberta.ca
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Scientific advances, population growth, lower mortality, and increasing complexity of diseases have boosted up the number of patients requiring prolonged breathing assistance with mechanical ventilators in the pediatric intensive care units (PICU) in many parts of the developed world. Previous studies also suggest that there is a small group of children who actually need such a high level of support for extended periods of time, utilizing a lot of human and technical resources. We defined children with prolonged mechanical ventilation (PMV) if they required supports with a breathing machine for more than 14 days. We propose an international point prevalence study of children requiring PMV in PICU. We will conduct the study in multiple centers in several different regions, including North and South America, Europe, and Asian countries, with a strong relationship with local physician colleagues. Practice for patients requiring PMV will be examined including the type and size of local PICU, admission and discharge policies, and patient and treatment modalities administered to such patients, types of professionals looking after patients in PMV, types of health care. We anticipate a high variability in practices suggesting a need to further standardize the management of PMV.. Specifically, as an immediate consequence, by comparing and understanding the differences in patient demographics, practice details among PICUs in regards to the background factors of local PICUs and their patients, practitioners will share their way of dealing with such patients. In that way, this study will support the need to generate guidelines and lead to patient care improvement in PICUs.


Recruitment information / eligibility

Status Recruiting
Enrollment 6000
Est. completion date September 4, 2022
Est. primary completion date September 3, 2021
Accepts healthy volunteers
Gender All
Age group 37 Weeks to 18 Years
Eligibility Inclusion Criteria:

Patients who are ventilated >14 consecutive days (after 37 weeks postmenstrual post-conception age)*

- including for more than 6 hours per day including on InMV and NIV duration

- patient who have had and short interruptions (<48hours) of ventilation during the weaning process as the same episode of ventilation can be included.

- InMV can be administered through an endotracheal tube or a tracheostomy tube.

- NIV can be managed through a nasal, full-face, total facial mask, or helmet.

- Patient on HFNC will be included as on respiratory support if they have a proper or a nasal cannula (that allows >=1 liters/kg/min (LPM) and >4LPM).

- We define nasal oxygen supply <1 L/kg/min as non-NIV practice.

Exclusion Criteria:

- Age >18 years

- Already included in this study

- No consent if required

- Brain death

- Premature children not yet at 37 weeks gestational age.

Study Design


Related Conditions & MeSH terms

  • Prolonged Mechanical Ventilation in Pediatric Intensive Care Unit

Intervention

Other:
prolonged mechanical ventilation
No intervention will be applied in this study

Locations

Country Name City State
Canada CHU Sainte Justine Montreal Quebec

Sponsors (5)

Lead Sponsor Collaborator
St. Justine's Hospital Fonds de la Recherche en Santé du Québec, Réseau en Santé Respiratoire du Québec, Réseau mère-enfant de la francophonie, Women and Children's Health Research Institute, Canada

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Prevalence of PMV number of patients meet PMV criteria devided by the number of patients admitted in PICUs on the specific data collection date and time. eight times during two-year study period
Secondary Patient and treatment demographics patient demographics underlying chronic disease acute disease leading to InMV or to NIV (i.e. reason of PMV) co-morbidities (Cerebral palsy, Seizure disorder, etc.) type of airway access MV mode and the days of ventilations for each mode care providers (e.g. intensivists, pediatric intensivists, anesthesiologist, paediatrician, pulmonologist) Nurse : patient ratio failed extubations or not during PMV location of patients on PMV (PICU or step down unit under PICU staff or not)
Data from 8 study dates will be integrated into a summarized finding in the manuscript
eight times during two-year study period
Secondary Outcomes at 90days follow-up complications of mechanical ventilation mortality destination 90 days from the initial data collection